Bionic Medical Implants/Artificial Organs Market Size and Share | Industry analysis for 2030 (2023)

Bionic Medical Implants/Artificial Organs Market Overview

The bionic medical implants/artificial organs market is projected to reach US$22.17 billion by 2030, with a CAGR of 7.90% over the forecast period 2022-2030. Artificial organs and implants are special types of devices made to implant organs in the human body. It is mainly used to make the organs function or to indicate the original organ. Bionics is divided into parts and they are biology and electronics. Medical bionics are replaced robotic versions of damaged body parts.

Organ transplants become necessary when an organ in the body is damaged for whatever reason. However, there is also a possibility that the Brogan transplant may not be successful because the body sometimes rejects the organ transplant. It is a substance that is introduced into the body to improve the body and make it function as before. The most advanced bionic organs, heart and kidney, and the most advanced medical bionics are the pacemaker and the cochlea.

Covid-19-Analyse

The pandemic has hit most businesses, but the healthcare sector has gained momentum. The healthcare industry is the only industry that has improved its market. Due to the spread of the virus, people are relying on the healthcare sector for treatment, which has had a positive impact on the market. But due to the constant care of Covid patients, other patients have been ignored and not received the necessary treatment, which is a big problem for the market growth. As manufacturers and manufacturing facilities were forced to close and people were told to stay indoors to slow the spread, market closures and government quarantine orders negatively impacted the market.

Main factors that exist in the market

• key factors

Currently, the market is driven by the growing number of patients requiring organ transplants. However, a transplant is not possible for everyone because the number of donors is much smaller than the number of patients. The continuous advancement of technology in healthcare such as devices, treatments and diagnostics is driving the growth of the market. Various diseases and treatments are getting public attention and the advancements in artificial organs market process are helping the market to stand out. The development of 3D printers in the bionic medical implants/artificial organs market also impels the growth of the market over the forecast period. The increase in organ damage accidents and organ transplants are the main growth factor of the market. The rise of eye diseases with regulatory structure is also gaining market growth. Due to age-related problems and aging factors, people are experiencing organic failures which increases the growth of the market.

• market challenges

The smaller number of donors and the growing number of transplanted patients is a major challenge that the market has to overcome. Although the number of patients is increasing, advanced technology has not yet made all transplants a success, so the bionic medical implants/artificial organs market still faces several obstacles.

• market opportunities

Rapid advances in technology and government health initiatives are accelerating the market and creating a new opportunity for the common bionic medical implant market. People who are becoming more health conscious and getting screened from time to time are also creating a great opportunity for the market.

• Market Restrictions

The drivers are accelerating the market, but with the acceleration, several factors are also preventing the market from growing any further. The disadvantages of market preservation are the high cost of devices without insurance reimbursement. The development costs are high and thus fewer specialists for such challenging tasks, which also has a negative impact on market growth.

Cumulative market assessment

The cumulative market assessment reveals a number of researches conducted on the Bionic Medical Implants/Artificial Organs market to develop the overall market. Various segments as drivers and opportunities are accelerating the market and opening new avenues for new major players to invest in it. However, the key players must be aware of the market restraints and challenges to deal with and try to overcome them as quickly as possible to register high growth rate during the forecast period. The impact of COVID is also mentioned in the assessment of Bionic Medical Implants Market Outlook to give a new shape to the market and represent that the market is set to continue growing in the future.

market segmentation

• through technology

The market is segmented into mechanical and electronic bionics based on technology segment. Both segments enlarge the market and contribute to the market value of bionic medical implants.

• by-products

On the basis of segment product, the bionic medical implants/artificial organs market is categorized into Vision, Hearing, Orthopedics, Heart, Neural/Brain. Bionic vision was divided into the bionic eye. The bionic ear segment is divided into cochlear implants and bone conduction hearing aids. Orthopedic bionics is divided into bionic hand, bionic leg, bionic fingers, exoskeleton and electric bone growth stimulators. Bionic Leg sub-segments include Bionic Knees and Bionic Feet. Electrical bone growth stimulators include invasive bone growth stimulators and non-invasive bone growth stimulators. Heart bionics are divided into pacemakers, artificial hearts, heart support systems and artificial heart valves. The cardiac pacemaker includes an implantable cardiac pacemaker and an external cardiac pacemaker. The sub-segments of the artificial heart valve include the mechanical heart valve and the tissue heart valve. Segmented into Deep Brain Stimulators, Vagus Nerve Stimulators and Spinal Cord Stimulators, the Neural/Cerebral Bionics market is increasing the market size of Bionic Medical Implants.

• by fixation

Fixation of bionic medical implants/artificial organs market is segmented into implantable and externally used. Each segment variable drives and grows the market to secure a place in the global marketplace.

By the end user

The market for bionic medical implants/artificial organs is segmented into hospitals and clinics, academic and research institutes, among others.

regional analysis

The bionic medical implants/artificial organs market is studied in Americas, Asia-Pacific, Europe, Middle East, Africa and other countries. The United States is experiencing a high rate of growth due to the presence of major key players and the introduction of advanced bionic medical devices. Europe dominates the second market due to government support in the region for the region's development and research spending. Also due to the increase in cases of organ failure and other complications. Due to the increasing number of patients, increasing demand for advanced treatments, the development of the healthcare sector, the growth of healthcare in various Asian regions is increasing, directly accelerating the market growth. The Middle East and Africa is not showing the necessary growth as the region lacks technical knowledge and is not developing. Due to the poor medical care in the region, the market lacks a growth region. Other regions are seeing significant growth and are expected to increase the CAGr of the market. The Bionic Medical Implants Market analysis demonstrates the growth of the market across different regions.

Intensity of competition in the industry

Several major players are investing in the bionic medical implants/artificial organs market and expecting the market to grow during the forecast period. The market development is based on the strategies donated by prominent players for the market growth. The report consists of various details about the competitor. Also, much more details are presented in the report of competitors: market production, market dominance, finances, investments, profit and others. The major players are expected to improve the market value using various techniques. The intensity of competition among the market-leading investors will have a positive effect. Among the most important factors is the growth of the bionic medical implants market

• Aleva Neurotherapeutics S.A. Suiza


• Israel Medical Biocontrol


• Biomet, Inc. EE. UU.


• Boston Scientific Corporation EE. UU.


• cochlea ltd (Australia), Cyberonics, Inc. AND IS. UU.


• Ekso Bionics EE. UU.


• LivaNova PLC UK


• Medtronic, Inc. EE. UU.


• NeuroPace, Inc. EE. UU.


• Orthofix International N.V. Netherlands


• Island


• Second Sight Medical Products, Inc. EE. UU.


• St. Jude Medical, Inc. (EE. UU.).

the latest development

• The first pig-to-human transplant two months ago reported the operation's success, but patient David Bennet Sr., 57, died of unknown causes. Pig heart transplantation needs further improvement.


• Cyber ​​company Kaspersky is one of the first companies in the world to develop and implement a security policy covering the use of bionic devices and other forms of human augmentation.

Report Overview

• The report offers advanced and formative research findings. The data mentioned in the report is elaborated with adequate researches on the trends of Bionic Medical Implants market. The report also provides details on the market segmentation and how they affect the market growth over the forecast period. The impact of Covid-19, driving factors, restraints, highlights of key key players, and recent developments in the market are predicted in the Artificial Organs/Bionic Medical Implants Market report.

Main Industry Segments

through technology

• mechanic


• Electronic bionics

by-products

• Vision


• Ohr


• orthopedics


• Herz


• neural/brain

by fixation

• implantable


• worn externally

by end users

• hospitals


• clinics


• Academic and research institutes

Report scope:

Frequently Asked Questions (FAQ):